Ticker APRE – Aprea Thera – sales, description, marketcap – Tickerday.com

APRE

Aprea Thera

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 585.18M; Volume: 85.53K; AvgVol 3m: 82.79K; Beta: ;

Cost estimate:

P/E: ; EPS: 1.25; EPS growth quarter/prev quarter: -70.50%;

EPS growth this year: -64.90%; EPS growth past 5 years: ;

EPS ttm: -2.04;

P/S: ; P/B: 5.70; P/Cashflow: 5.27; P/FCF: ;

Sales: ; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -41.90%; ROE – return on equity: -67.60%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: ; Dividend Yield (%): ;

Insider Ownership: 12.94%; Insider Transactions:-37.53%;

Institutional Ownership: 90.00%; Institutional Transactions: 0.83%;

Data update: 07/10/2020.

Leave a comment

Your email address will not be published. Required fields are marked *